World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 November 2012
Main ID:  NCT00946816
Date of registration: 20/07/2009
Primary sponsor: University of Zurich
Public title: The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
Scientific title: The Effects of Dietary Intervention on Gastrointestinal Motility, Hormonal Feedback, Visceral Sensation and Satiety in Patients With Anorexia Nervosa and Obesity
Date of first enrolment: September 2010
Target sample size: 60
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00946816
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
Switzerland
Contacts
Name:   Michael Fried, Professor MD
Address: 
Telephone:
Email:
Affiliation:  University Hospital Zurich, Gastroenterology and Hepatology
Key inclusion & exclusion criteria

In addition to satisfying specific DSMIV criteria for anorexia nervosa (B1, B2) or WHO
criteria for obesity (C1), or obesity and diabetes mellitus type II (C2), general
inclusion criteria include:

- aged at least 18 and not more than 40 years

- able to communicate well with the investigators and provide written consent

- no physical co-morbidity requiring active treatment, in particular diabetes mellitus,
impairment of liver or kidney function (subjects with diabetes mellitus type II are
eligible for study group C2)

- no psychiatric (DSM IV) disorders limiting the ability to comply with study
requirements

- no use of medications influencing upper GI motility within one week of the study
(i.e. nitrates, prokinetic drugs, macrolide antibiotics). Acid suppression and
antihypertensive medication beta-blocker, calcium channel blockers are acceptable.

- no evidence of current drug or alcohol abuse

- no history of gastrointestinal disease or surgery except appendicectomy or hernia
repair

- females will take a urine pregnancy test before each study, any participant with a
positive pregnancy test will be excluded (females will be investigated always in the
same menstrual phase)

Exclusion criteria:

• pregnancy



Age minimum: 18 Years
Age maximum: 40 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Anorexia Nervosa
Healthy Participants
Obesity
Intervention(s)
Behavioral: Nutritional Intervention
Primary Outcome(s)
The GI response to a given meal in terms of: motility, neurohormonal feedback, sensation and satiety [Time Frame: 2 years]
Secondary Outcome(s)
Secondary ID(s)
SNF 320030_1253331
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Schweizerischer Nationalfonds
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history